Single pill treatment in daily practice is associated with improved clinical outcomes and all-cause mortality in cardiovascular diseases: results from the START project

Autor: B Weisser, T Wilke, H G Predel, R E Schmieder, S Wassmann, A Gillessen, J Blettenberg, U Maywald, O Randerath, A Mevius, M Boehm

Publikováno v: European Heart Journal. 43

Objective Current guidelines for the management of arterial hypertension, dyslipidemia, or secondary cardiovascular (CV) prevention recommend combination drug treatments with single pill combinations (SPC). This concept is expected to improve adheren

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ee4ebbf09b8813714ccc7c62c4a95906
https://doi.org/10.1093/eurheartj/ehac544.2254

Persistence and cardiovascular outcomes with ramipril, atorvastatin, ASA as a single pill compared to the multi pill combination. A subanalysis of the START study, a claims data analysis

Autor: Roland E. Schmieder, Michael Boehm, O Randerath, J Blettenberg, Sven Wassmann, A Noetel, V Fournier, Hans-Georg Predel, A Gillessen, Burkhard Weisser

Publikováno v: European Heart Journal. 41

Background/Introduction Large randomized clinical trials have shown the efficacy of aspirin (ASA), angiotensin converting enzyme inhibitors (ACEI) and statins (S) in secondary prevention. However, adherence to medication is low in patients suffering

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b3f4e3ff2f2eeb0f68b0cbbf1802a200
https://doi.org/10.1093/ehjci/ehaa946.2964

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Effect of a single pill concept on clinical and pharmacoeconomic outcomes in cardiovascular diseases.

Autor: Weisser B; Institute of Sports Science, Christian-Albrechts-University of Kiel, Kiel, Germany., Wassmann S; Cardiology Pasing, Munich, and Faculty of Medicine, University of the Saarland, Homburg/Saar, Germany., Predel HG; Institute of Cardiology and Sports Medicine, German Sport University, Cologne, Germany., Schmieder RE; Department of Nephrology and Hypertension, University Hospital Erlangen, Friedrich Alexander University Erlangen Nürnberg, Erlangen, Germany., Gillessen A; Department of Internal Medicine, Herz-Jesu-Hospital, Münster, Germany., Wilke T; Institut für Pharmakoökonomie und Arzneimittellogistik (IPAM)/Institute for Pharmacoeconomics and Pharmaceutical Logistics, Wismar, Germany., Blettenberg J; Practice Dr. J. Blettenberg, Lindlar, Germany., Randerath O; Medical Department, APONTIS PHARMA Deutschland GmbH & Co.KG, Monheim, Germany., Mevius A; Institut für Pharmakoökonomie und Arzneimittellogistik (IPAM)/Institute for Pharmacoeconomics and Pharmaceutical Logistics, Wismar, Germany., Böhm M; Clinic for Internal Medicine III, University Clinic of Saarland, Saarland University, Homburg/Saar, Germany.

Publikováno v: European heart journal. Cardiovascular pharmacotherapy [Eur Heart J Cardiovasc Pharmacother] 2024 Jul 31. Date of Electronic Publication: 2024 Jul 31.